This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Frequent budget adjustments help you respond to income shifts and spending surprises. This intro guides quick, practical tweaks for staying on track.
26,559 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Paradigm just closed a $1.2B fund, signaling a bold move at the intersection of crypto and AI. This Morning Minute ex...
As GoodRx navigates evolving discount dynamics and a changing membership model, the 2025 earnings picture will hinge ...
A top China logistics platform generated $1.8 billion in revenue last year, yet one investor cashed out a $6 million ...
A Chinese open-weights AI model stirred markets and sent Nvidia shares lower. This piece explains why the dip could a...
Geopolitical shocks echoed through crypto flows as Iranian exchanges saw a dramatic outflow spike totaling $10.3 mill...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
As AI expands, the backbone assets—storage, memory, and data-center hardware—could power surprising gains. This artic...
Target stock surged after the latest earnings release, sending investors back to the question: is this the start of a...
Investors are eyeing Vera Bradley's 2026 path as it rhythms through product launches, wholesale relationships, and di...
AST SpaceMobile has fallen from its highs even after a sizable funding round. This article explains why the fade in s...
Thursday brought a lift to D-Wave stock as a quarterly momentum signal emerged. This guide breaks down the catalysts ...